Jan 18, 2008 by Brian LawlerWrong-Way Regulators in EuropeIf they want more new drugs, they shouldn't be looking at the pharmaceutical industry.
Jan 17, 2008 by Brian LawlerThe Good Times Roll for PharmassetShares ride high after the company releases positive clinical trial data.
Jan 16, 2008 by Brian LawlerAnother Inhalable Insulin Bites the DustNovo Nordisk discontinues development of the troubled diabetes treatment.
Jan 16, 2008 by Brian LawlerMore Tysabri on the WayBiogen and Elan receive an additional approval for Tysabri.
Jan 16, 2008 by Brian LawlerTalking With a Development-Stage PharmaAn interview with development-stage drugmaker Pharmacopeia.
Jan 16, 2008 by Brian LawlerBetter Safe Than Sorry at TheravanceThe pharma raises cash ahead of an FDA hearing.
Jan 14, 2008 by Brian LawlerWorst Stock for 2008: PfizerPfizer is a good company, but a bad stock for 2008.
Jan 14, 2008 by Brian LawlerScore One for Dendreon and DisclosureA prestigious journal supports Dendreon and makes a compelling case for more FDA disclosure.
Jan 9, 2008 by Brian LawlerTracking GenzymeThe biopharma updates investors on what to expect for 2008.
Jan 9, 2008 by Brian LawlerChecking In on BiogenBiogen presents at the JPMorgan Healthcare Conference.
Jan 8, 2008 by Brian LawlerCelgene Looks Both WaysThe drug company presents 2007's numbers and gives 2008 guidance.
Jan 8, 2008 by Brian LawlerInterMune Goes Step by StepThe company updates investors on the progress of its lead drug for hepatitis C.
Dec 31, 2007 by Brian LawlerBest Stock for 2008: Gilead SciencesShares of Gilead Sciences are a good bet for next year.
Dec 31, 2007 by Brian LawlerThe Biotech Year in ReviewA look at the highlights and lowlights of 2007.
Dec 31, 2007 by Brian LawlerDoes Leadership Count at the FDA?Taking a look at how drug approval rates have fared under different FDA commissioners.
Dec 31, 2007 by Brian LawlerLower Expectations for TheravanceThe FDA decides to debate the company's lead drug.
Dec 31, 2007 by Brian LawlerBig Pharma 2008 Forecast RoundupTaking a look at what 2008 has in store for big pharma.
Dec 31, 2007 by Brian LawlerCephalon's Date With the FDAThe pharmaceutical files another marketing application.
Dec 31, 2007 by Brian LawlerThe Anatomy of an Approved DrugHere's what a newly approved drug looks like.
